Corporate Site
Skip to main content

Governance

Corporate Site

At QuidelOrtho, we are committed to conducting our business in accordance with all applicable laws, rules, and regulations, and the highest ethical standards. This section includes documents regarding the Company's corporate governance practices, evidencing the Company's commitment to sound principles of corporate governance.

Corporate Governance Documents

Download item year list
Download Description
Code of Business Conduct and Ethics (opens in new window)
Corporate Governance Guidelines (opens in new window)
Compliance Program (opens in new window)
California Transparency in Supply Chains Act Disclosure (opens in new window)
Conflict Minerals Policy (opens in new window)
2023 Conflict Minerals Report (opens in new window)
Whistleblower Policy (opens in new window)

Committee Charters

Download item year list
Download Description
Audit Committee (opens in new window)
Compensation Committee (opens in new window)
Nominating and Corporate Governance Committee (opens in new window)
Science and Technology Committee (opens in new window)
Lead Independent Director (opens in new window)

QuidelOrtho’s Comprehensive Compliance Program, Code of Business Conduct and Ethics, and Annual Written Declaration may be obtained by calling 800-874-1517.

Board of Directors

Kenneth F. Buechler, Ph.D., Chairman of QuidelOrtho Corporation
Founder And Former President, Chief Scientific Officer Of Biosite, Inc.

Brian J. Blaser, President and Chief Executive Officer Of QuidelOrtho Corporation

John R. Chiminski, Former Chairman, President and Chief Executive Officer Of Catalent, Inc.

Evelyn S. Dilsaver, Former President And CEO Of Charles Schwab Investment Management

R. Scott Huennekens, Former Chairman, President And Chief Executive Officer Of Verb Surgical, Inc.

Edward L. Michael, Managing Partner And Co-founder Of Lionbird Ventures
Former Executive Vice President, Diagnostic Products Of Abbott Laboratories

Mary Lake Polan, M.D., Ph.D., M.P.H., Professor Of Clinical Obstetrics, Gynecology And Reproductive Sciences Of Yale University School of Medicine

Ann D. Rhoads, Former Chief Financial Officer of Forty Seven, Inc.

Matthew W. Strobeck, Ph.D., Managing Partner of Birchview Capital

Kenneth J. Widder, M.D., Chief Executive Officer of Sydnexis Inc.

Joseph D. Wilkins Jr., Managing Director, JW Healthcare Insights
Former Executive Of Atlantic Health System, Quest Diagnostics, And Danaher-beckman Coulter

Committee Composition

Board Skills Matrix

 

Skills and Expertise Blaser Buechler Chiminski Dilsaver Huennekens Michael Polan Rhoads Strobeck Widder Wilkins
Strategy and Strategic Planning, including Profitable Growth Strategies ● ● ● ● ● ● ● ● ● ●
Operational Efficiency and Cost Discipline ● ● ● ● ● ● ● ● ●
Sales and Marketing ● ● ● ● ● ● ●
Corporate Finance and M&A ● ● ● ● ● ● ● ● ● ●
Financial Expertise and Acumen ● ● ● ● ● ● ● ● ●
Research and Development ● ● ● ● ● ● ● ●
International Operations ● ● ● ● ● ●
Regulatory and Compliance ● ● ● ● ● ● ● ● ●
Information Technology, Cybersecurity and Data Privacy ● ● ● ● ● ●
Human Capital Management ● ● ● ● ● ● ● ●
Environmental, Social and Governance / Sustainability ● ● ● ● ●
Risk Management ● ● ● ● ● ● ● ●
Experiences Skills and Expertise Blaser Buechler Chiminski Dilsaver Huennekens Michael Polan Rhoads Strobeck Widder Wilkins
CEO Leadership ● ● ● ● ●
Senior Management Leadership ● ● ● ● ● ● ● ● ● ●
Significant Technical, Advisory or Business Experience in Medical Diagnostics ● ● ● ● ●
Public Company Board Experience (other than on QuidelOrtho’s Board) ● ● ● ● ● ● ● ● ●

ANIMAL WELFARE

Quidel does not undertake any animal testing or outsource any animal testing to any third party.